Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine
Could a corporate, direct-to-consumer cell-based testing service be the next 23andme? And what would that mean for patients?
Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine
